D. Gill

发表

Rhodium-103 NMR evidence for charge separation and fluxionality among rhodium atoms in metal clusters

J. Vidal, O. Gansow, R. C. Schoening, 1980 .

Pentamethylcyclopentadienyl-rhodium and -iridium complexes : VIII. Di-μ-hydridobis[chloro(pentamethylcyclopentadienyl)iridium] and related compounds☆

P. Maitlis, D. Gill, 1975 .

Structure Activity Relationship of Antitumor Palladium Complexes

D. Gill, 1984 .

Pentamethylcyclopentadienyl-rhodium and -iridium complexes. Part 16. Homogeneous hydrogenation catalysts

P. Maitlis, D. Gill, C. White, 1978 .

µ-Chloro-µ-hydrido-dichlorobis(pentamethylcyclopentadienyl)di-rhodium and -iridium as homogenous hydrogenation catalysts

P. Maitlis, J. Kang, Hing-Biu Lee, 1971 .

Syntheses, kinetics, and mechanism of formation of polynuclear hydroxo-bridged complexes of (trans-1,2-diaminocyclohexane)platinum(II)

B. Rosenberg, D. Gill, 1982 .

Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).

Lawrence X. Yu, Lawrence X Yu, A. Raw, 2004, Advanced drug delivery reviews.

Pharmaceutical impurities: regulatory perspective for Abbreviated New Drug Applications.

Lawrence X. Yu, A. Raw, D. Gill, 2007, Advanced drug delivery reviews.